echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > THER ADV GASTROENTER: Long-term efficacy of moxibustion on diarrhea-predominant irritable bowel syndrome

    THER ADV GASTROENTER: Long-term efficacy of moxibustion on diarrhea-predominant irritable bowel syndrome

    • Last Update: 2022-04-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder
    .


    Its main clinical manifestations include abdominal pain, bloating, and changes in bowel habits (diarrhea, constipation), and the pathogenesis of the disease is unclear, so the diagnosis of IBS is mainly based on clinical symptoms


    Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder


     

    The researchers assigned IBS-D patients to receive moxibustion or sham moxibustion (52 treatments each, 3 times a week for 6 weeks) and followed up for 24 weeks
    .


    The acupoints were selected bilaterally ST25 and ST36, and the body surface temperature of each acupoint in the moxibustion group and the sham operation group were 43℃±1℃ and 37℃±1℃, respectively


     

    According to intention-to-treat analysis, the incidence of IBS-AR in the moxibustion group was significantly higher than that in the sham operation group at 6 weeks (76.
    9% vs 42.
    3%; p < 0.
    001); the average decrease in the total score of IBS-BSS in the moxibustion group was lower than that in the moxibustion group.
    In the sham group (-116.
    9 VS -61.
    5; p < 0.
    001), both remained unchanged throughout follow-up
    .


    At week 6, the rate of >50-point reduction in IBS-SSS was significantly higher in the treatment group than in the sham group (p < 0.


    Photo: Degree in Moxibustion

     

    This study demonstrated that moxibustion for ST25 and ST36 was associated with sustained beneficial clinical effects when treating IBS-D patients for at least 24 weeks
    .


    Moxibustion therapy is beneficial for long-term relief of symptoms in patients with IBS-D


          This study demonstrated that moxibustion for ST25 and ST36 was associated with sustained beneficial clinical effects when treating IBS-D patients for at least 24 weeks


     

    Original source:

    Chunhui Bao.


    Long-term effect of moxibustion on irritable bowel syndrome with diarrhea: a randomized clinical trial.
    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.